- Schrödinger (SDGR, Financial) announced new inducement grants to seven newly hired employees as of April 16, 2025.
- The grants involve a stock option for 3,300 shares and RSUs for 12,866 shares.
- These actions align with the Nasdaq Listing Rule 5635(c)(4) under the company's 2021 Inducement Equity Incentive Plan.
Schrödinger, Inc. (SDGR) has disclosed the issuance of inducement grants to seven new employees, effective April 16, 2025. The grants include a non-statutory stock option enabling the purchase of 3,300 shares of company stock at an exercise price of $25.21 per share, corresponding to the closing price of SDGR stock on the grant date. This option is awarded to one employee and features a ten-year term with a vesting schedule of 25% after the first year and the remainder vesting monthly over the next 36 months.
In addition, six employees have been granted restricted stock units (RSUs) covering 12,866 shares. The RSUs are set to vest over four years, with 25% of the shares vesting after 12 months and the remainder in successive equal annual installments over the next three years. These grants fall under Schrödinger's 2021 Inducement Equity Incentive Plan and are elicited as a material inducement for employment acceptance, adhering to Nasdaq Listing Rule 5635(c)(4).
The grants are subject to specific terms and conditions covered under award agreements and the company's equity incentive plan guidelines. Schrödinger continues to pioneer molecular discovery using a computational platform that supports novel drug development and material design, contributing significantly to its ongoing collaborations and proprietary project advancements.
